ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of October 14, 2026, CLPT trades at $9.28 with a market cap of $299.25M and a P/E ratio of -15.34. CLPT moved -5.71% today. Year to date, CLPT is -34.14%; over the trailing twelve months it is -64.50%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CLPT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $9.28 |
| Market Cap | $299.25M |
| P/E Ratio | -15.34 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.10 |
| 52-Week Low | $8.27 |
| Volume | 912.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.39M |
| Net Income | $-18.91M |
| Gross Margin | 60.92% |
2 analysts cover CLPT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.